Literature DB >> 10531423

Neuronal nitric oxide synthase mRNA upregulation in rat sensory neurons after spinal nerve ligation: lack of a role in allodynia development.

Z D Luo1, S R Chaplan, B P Scott, D Cizkova, N A Calcutt, T L Yaksh.   

Abstract

Pharmacological evidence suggests a functional role for spinal nitric oxide (NO) in the modulation of thermal and/or inflammatory hyperalgesia. To assess the role of NO in nerve injury-induced tactile allodynia, we examined neuronal NO synthase (nNOS) expression in the spinal cord and dorsal root ganglia (DRG) of rats with tactile allodynia because of either tight ligation of the left fifth and sixth lumbar spinal nerves or streptozotocin-induced diabetic neuropathy. RNase protection assays indicated that nNOS mRNA (1) was upregulated in DRG, but not spinal cord, neurons on the injury side beginning 1 d after nerve ligation, (2) peaked (approximately 10-fold increase) at 2 d, and (3) remained elevated for at least 13 weeks. A corresponding increase in DRG nNOS protein was also observed and localized principally to small and occasionally medium-size sensory neurons. In rats with diabetic neuropathy, there was no significant change in DRG nNOS mRNA. However, similar increases in DRG nNOS mRNA were observed in rats that did not develop allodynia after nerve ligation and in rats fully recovered from allodynia 3 months after the nerve ligation. Systemic treatment with a specific pharmacological inhibitor of nNOS failed to prevent or reverse allodynia in nerve-injured rats. Thus, regulation of nNOS may contribute to the development of neuronal plasticity after specific types of peripheral nerve injury. However, upregulation of nNOS is not responsible for the development and/or maintenance of allodynia after nerve injury.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10531423      PMCID: PMC6782898     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  53 in total

1.  Rescue of alpha-SNS sodium channel expression in small dorsal root ganglion neurons after axotomy by nerve growth factor in vivo.

Authors:  S D Dib-Hajj; J A Black; T R Cummins; A M Kenney; J D Kocsis; S G Waxman
Journal:  J Neurophysiol       Date:  1998-05       Impact factor: 2.714

2.  Retrograde transport of plasticity signals in Aplysia sensory neurons following axonal injury.

Authors:  J D Gunstream; G A Castro; E T Walters
Journal:  J Neurosci       Date:  1995-01       Impact factor: 6.167

Review 3.  The changing scene of neurotrophic factors.

Authors:  H Thoenen
Journal:  Trends Neurosci       Date:  1991-05       Impact factor: 13.837

4.  NMDA receptor activation induces glutamate release through nitric oxide synthesis in guinea pig dentate gyrus.

Authors:  K Nei; S Matsuyama; H Shuntoh; C Tanaka
Journal:  Brain Res       Date:  1996-07-22       Impact factor: 3.252

5.  Stimulation of nitric oxide release from rat spinal cord by prostaglandin E2.

Authors:  M Sakai; T Minami; N Hara; I Nishihara; H Kitade; Y Kamiyama; K Okuda; H Takahashi; H Mori; S Ito
Journal:  Br J Pharmacol       Date:  1998-03       Impact factor: 8.739

6.  Spinal pharmacology of tactile allodynia in diabetic rats.

Authors:  N A Calcutt; S R Chaplan
Journal:  Br J Pharmacol       Date:  1997-12       Impact factor: 8.739

7.  Regulation of acetylcholinesterase mRNA stability by calcium during differentiation from myoblasts to myotubes.

Authors:  Z Luo; M E Fuentes; P Taylor
Journal:  J Biol Chem       Date:  1994-11-04       Impact factor: 5.157

8.  Neuropathic pain in rats is associated with altered nitric oxide synthase activity in neural tissue.

Authors:  Y Choi; S N Raja; L C Moore; J R Tobin
Journal:  J Neurol Sci       Date:  1996-06       Impact factor: 3.181

9.  NMDA-dependent nitric oxide release in the hippocampus in vivo: interactions with noradrenaline.

Authors:  D Luo; S R Vincent
Journal:  Neuropharmacology       Date:  1994-11       Impact factor: 5.250

10.  NMDA-dependent prostaglandin E2 release by human cultured astroglial cells is driven by nitric oxide.

Authors:  V Mollace; M Colasanti; P Rodino; G M Lauro; D Rotiroti; G Nistico
Journal:  Biochem Biophys Res Commun       Date:  1995-10-24       Impact factor: 3.575

View more
  22 in total

Review 1.  The role of nitric oxide in nociception.

Authors:  Z D Luo; D Cizkova
Journal:  Curr Rev Pain       Date:  2000

2.  Neuronal nitric oxide synthase is upregulated in a subset of primary sensory afferents after nerve injury which are necessary for analgesia from alpha2-adrenoceptor stimulation.

Authors:  Weiya Ma; James C Eisenach
Journal:  Brain Res       Date:  2006-11-17       Impact factor: 3.252

3.  PDZ domains at excitatory synapses: potential molecular targets for persistent pain treatment.

Authors:  Yuan-Xiang Tao; Roger A Johns
Journal:  Curr Neuropharmacol       Date:  2006-07       Impact factor: 7.363

Review 4.  Redox regulation of neuronal voltage-gated calcium channels.

Authors:  Slobodan M Todorovic; Vesna Jevtovic-Todorovic
Journal:  Antioxid Redox Signal       Date:  2013-10-25       Impact factor: 8.401

5.  Expression of P2X5 receptors in the rat, cat, mouse and guinea pig dorsal root ganglion.

Authors:  Jun-Wei Zeng; Sai-Yu Cheng; Xiao-Hong Liu; Yan-Dong Zhao; Zhi Xiao; Geoffrey Burnstock; Huai-Zhen Ruan
Journal:  Histochem Cell Biol       Date:  2012-11-18       Impact factor: 4.304

6.  Upregulation of dorsal root ganglion (alpha)2(delta) calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats.

Authors:  Z D Luo; S R Chaplan; E S Higuera; L S Sorkin; K A Stauderman; M E Williams; T L Yaksh
Journal:  J Neurosci       Date:  2001-03-15       Impact factor: 6.167

7.  AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathic pain.

Authors:  Barbara Costa; Dario Siniscalco; Anna Elisa Trovato; Francesca Comelli; Maria Luisa Sotgiu; Mariapia Colleoni; Sabatino Maione; Francesco Rossi; Gabriella Giagnoni
Journal:  Br J Pharmacol       Date:  2006-06-12       Impact factor: 8.739

8.  Effects of Repetitive Transcranial Magnetic Stimulation on Astrocytes Proliferation and nNOS Expression in Neuropathic Pain Rats.

Authors:  Lu Yang; Sai-Hua Wang; Yan Hu; Yan-Fang Sui; Tao Peng; Tie-Cheng Guo
Journal:  Curr Med Sci       Date:  2018-06-22

9.  A nitric oxide (NO)-releasing derivative of gabapentin, NCX 8001, alleviates neuropathic pain-like behavior after spinal cord and peripheral nerve injury.

Authors:  Wei-Ping Wu; Jing-Xia Hao; Ennio Ongini; Francesco Impagnatiello; Cristina Presotto; Zsuzsanna Wiesenfeld-Hallin; Xiao-Jun Xu
Journal:  Br J Pharmacol       Date:  2003-12-08       Impact factor: 8.739

10.  Repeated treatment with the synthetic cannabinoid WIN 55,212-2 reduces both hyperalgesia and production of pronociceptive mediators in a rat model of neuropathic pain.

Authors:  B Costa; M Colleoni; S Conti; A E Trovato; M Bianchi; M L Sotgiu; G Giagnoni
Journal:  Br J Pharmacol       Date:  2003-12-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.